Efficacy of cetuximab and mutant selective EGFR inhibitor WZ4002 in EGFR T790M and non-T790M models of erlotinib resistant non-small cell lung cancer

被引：1
|
作者：
Tricker, Erin M. [1 ]
Xu, Chunxiao [1 ]
Wong, Kwok-Kin [1 ]
Janne, Pasi A. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2595
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations
    Janjigian, Yelena Y.
    Smit, Egbert F.
    Groen, Harry J. M.
    Horn, Leora
    Gettinger, Scott
    Camidge, D. Ross
    Riely, Gregory J.
    Wang, Bushi
    Fu, Yali
    Chand, Vikram K.
    Miller, Vincent A.
    Pao, William
    CANCER DISCOVERY, 2014, 4 (09) : 1036 - 1045
  • [32] Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer
    Lee, Eun Hye
    Kwak, Se Hyun
    Kim, Kyeong Yeon
    Kim, Chi Young
    Lee, Sang Hoon
    Heo, Seok-Jae
    Chang, Yoon Soo
    Kim, Eun Young
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [33] Noninvasive detection of EGFR T790M mutation in gefitinib resistant non-small cell lung cancer using mutant-enriched PCR
    He, Chen
    Zheng, Lixia
    Xu, Yuzhong
    Liu, Ming
    Li, Yuanguang
    Xu, Jun
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [34] An evaluation of aumolertinib for the treatment of EGFR T790M mutation-positive non-small cell lung cancer
    Wang, Jingyi
    Wu, Lin
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (06) : 647 - 652
  • [35] Osimertinib for the Treatment of Metastatic EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
    Khozin, Sean
    Weinstock, Chana
    Blumenthal, Gideon M.
    Cheng, Joyce
    He, Kun
    Zhuang, Luning
    Zhao, Hong
    Charlab, Rosane
    Fan, Ingrid
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2131 - 2135
  • [36] Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
    Skoulidis, Ferdinandos
    Papadimitrakopoulou, Vassiliki A.
    CLINICAL CANCER RESEARCH, 2017, 23 (03) : 618 - 622
  • [37] AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations
    Ren Zhao
    Shun Zhou
    Bing Xia
    Cui-ying Zhang
    Ping Hai
    Hong Zhe
    Yan-yang Wang
    BMC Cancer, 16
  • [38] Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
    Corallo, Salvatore
    D'Argento, Ettore
    Strippoli, Antonia
    Basso, Michele
    Monterisi, Santa
    Rossi, Sabrina
    Cassano, Alessandra
    Barone, Carlo M.
    TARGETED ONCOLOGY, 2017, 12 (02) : 153 - 161
  • [39] Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
    Salvatore Corallo
    Ettore D’Argento
    Antonia Strippoli
    Michele Basso
    Santa Monterisi
    Sabrina Rossi
    Alessandra Cassano
    Carlo M. Barone
    Targeted Oncology, 2017, 12 : 153 - 161
  • [40] Clinicopathological Characteristics of Non-small Cell Lung Cancer Patients With Primary Concomitant EGFR T790M Mutation
    Li, Hang
    Wang, Rui
    Hu, Haichuan
    Pan, Yunjian
    Wang, Lei
    Zhang, Yang
    Sun, Yihua
    Chen, Haiquan
    CHEST, 2014, 145 (03)
12345